Michael Lawrence Barnett, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skilled Nursing Facilities | 14 | 2023 | 372 | 5.670 |
Why?
|
Analgesics, Opioid | 20 | 2023 | 3667 | 3.370 |
Why?
|
Opioid-Related Disorders | 18 | 2023 | 2062 | 3.200 |
Why?
|
Medicare | 44 | 2024 | 6532 | 3.110 |
Why?
|
Telemedicine | 18 | 2023 | 2853 | 2.630 |
Why?
|
Nursing Homes | 9 | 2023 | 1034 | 2.530 |
Why?
|
Drug Prescriptions | 11 | 2021 | 1636 | 2.410 |
Why?
|
Primary Health Care | 19 | 2022 | 4551 | 2.300 |
Why?
|
Nurse Practitioners | 6 | 2023 | 270 | 2.230 |
Why?
|
Buprenorphine | 9 | 2023 | 640 | 2.210 |
Why?
|
Physicians | 18 | 2024 | 4554 | 2.170 |
Why?
|
Specialization | 8 | 2021 | 777 | 2.150 |
Why?
|
Reimbursement Mechanisms | 7 | 2021 | 670 | 2.070 |
Why?
|
Narcotic Antagonists | 6 | 2023 | 562 | 1.920 |
Why?
|
Medicare Part C | 7 | 2024 | 296 | 1.850 |
Why?
|
Ambulatory Care | 8 | 2021 | 2706 | 1.830 |
Why?
|
Physicians, Primary Care | 9 | 2022 | 577 | 1.690 |
Why?
|
United States | 92 | 2024 | 69693 | 1.680 |
Why?
|
Remote Consultation | 3 | 2021 | 238 | 1.650 |
Why?
|
Physician Assistants | 4 | 2023 | 193 | 1.470 |
Why?
|
Residential Treatment | 2 | 2021 | 111 | 1.410 |
Why?
|
Medicine | 5 | 2022 | 941 | 1.400 |
Why?
|
Referral and Consultation | 8 | 2022 | 3527 | 1.190 |
Why?
|
Nursing Staff | 3 | 2021 | 129 | 1.100 |
Why?
|
Health Services Accessibility | 11 | 2022 | 5133 | 1.090 |
Why?
|
Fee-for-Service Plans | 8 | 2022 | 694 | 1.080 |
Why?
|
Subacute Care | 4 | 2020 | 168 | 1.030 |
Why?
|
Respiratory Tract Infections | 5 | 2023 | 959 | 0.950 |
Why?
|
Pandemics | 20 | 2024 | 8328 | 0.890 |
Why?
|
Medicaid | 5 | 2019 | 2716 | 0.870 |
Why?
|
Delivery of Health Care | 6 | 2023 | 5304 | 0.840 |
Why?
|
Interprofessional Relations | 4 | 2019 | 1008 | 0.830 |
Why?
|
Ivermectin | 1 | 2022 | 42 | 0.830 |
Why?
|
Humans | 137 | 2024 | 742088 | 0.830 |
Why?
|
Long-Term Care | 3 | 2022 | 607 | 0.820 |
Why?
|
Health Expenditures | 7 | 2021 | 2346 | 0.790 |
Why?
|
Health Facility Administrators | 1 | 2021 | 31 | 0.780 |
Why?
|
Insurance Coverage | 4 | 2023 | 1895 | 0.770 |
Why?
|
Personnel Turnover | 1 | 2021 | 83 | 0.750 |
Why?
|
Mythology | 1 | 2020 | 15 | 0.740 |
Why?
|
Dental Care | 1 | 2023 | 262 | 0.730 |
Why?
|
Economics, Hospital | 2 | 2019 | 213 | 0.720 |
Why?
|
Arthroplasty, Replacement | 2 | 2020 | 336 | 0.700 |
Why?
|
Infection Control | 3 | 2021 | 962 | 0.680 |
Why?
|
Health Personnel | 4 | 2023 | 3210 | 0.670 |
Why?
|
Patient Transfer | 3 | 2017 | 760 | 0.670 |
Why?
|
Gatekeeping | 1 | 2018 | 45 | 0.660 |
Why?
|
Aged | 49 | 2024 | 162944 | 0.660 |
Why?
|
Preferred Provider Organizations | 1 | 2018 | 38 | 0.650 |
Why?
|
Benzodiazepines | 3 | 2023 | 1101 | 0.650 |
Why?
|
Heroin Dependence | 1 | 2019 | 175 | 0.640 |
Why?
|
Insurance, Health | 4 | 2023 | 2493 | 0.640 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 408 | 0.630 |
Why?
|
Oxycodone | 2 | 2022 | 152 | 0.620 |
Why?
|
Guideline Adherence | 3 | 2021 | 2266 | 0.620 |
Why?
|
Drug Utilization | 4 | 2020 | 1181 | 0.610 |
Why?
|
Government Regulation | 2 | 2020 | 522 | 0.600 |
Why?
|
Back Pain | 1 | 2021 | 545 | 0.590 |
Why?
|
Substance-Related Disorders | 4 | 2022 | 4250 | 0.590 |
Why?
|
Managed Care Programs | 3 | 2018 | 949 | 0.580 |
Why?
|
Health Services Research | 4 | 2019 | 1834 | 0.570 |
Why?
|
Patient Discharge | 7 | 2023 | 3300 | 0.570 |
Why?
|
Quality of Health Care | 5 | 2023 | 4369 | 0.570 |
Why?
|
Salaries and Fringe Benefits | 1 | 2019 | 264 | 0.560 |
Why?
|
Psychiatry | 4 | 2022 | 1695 | 0.550 |
Why?
|
Anti-Bacterial Agents | 8 | 2023 | 7153 | 0.540 |
Why?
|
Rural Health Services | 1 | 2019 | 379 | 0.540 |
Why?
|
Health Maintenance Organizations | 1 | 2018 | 642 | 0.530 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3130 | 0.530 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9274 | 0.530 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3236 | 0.520 |
Why?
|
Medically Uninsured | 2 | 2019 | 852 | 0.510 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 24913 | 0.500 |
Why?
|
Medical Staff, Hospital | 1 | 2019 | 603 | 0.490 |
Why?
|
Behavior Therapy | 1 | 2020 | 866 | 0.490 |
Why?
|
Home Care Services | 1 | 2021 | 602 | 0.490 |
Why?
|
Accreditation | 1 | 2017 | 449 | 0.480 |
Why?
|
Outpatients | 7 | 2024 | 1483 | 0.470 |
Why?
|
Education, Medical | 2 | 2023 | 1717 | 0.470 |
Why?
|
Cost Savings | 1 | 2019 | 925 | 0.470 |
Why?
|
Intelligence | 1 | 2019 | 920 | 0.470 |
Why?
|
Policy Making | 1 | 2017 | 554 | 0.460 |
Why?
|
Bronchitis | 1 | 2014 | 201 | 0.460 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1768 | 0.460 |
Why?
|
Electronic Health Records | 4 | 2020 | 4440 | 0.450 |
Why?
|
Health Plan Implementation | 1 | 2016 | 351 | 0.450 |
Why?
|
Personal Satisfaction | 1 | 2017 | 634 | 0.440 |
Why?
|
Education | 1 | 2016 | 543 | 0.430 |
Why?
|
Patient Admission | 1 | 2020 | 1380 | 0.430 |
Why?
|
Aftercare | 2 | 2023 | 860 | 0.430 |
Why?
|
Antipsychotic Agents | 3 | 2023 | 3058 | 0.420 |
Why?
|
Prescriptions | 4 | 2023 | 387 | 0.420 |
Why?
|
Population Surveillance | 1 | 2023 | 2616 | 0.420 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2012 | 30 | 0.420 |
Why?
|
Cause of Death | 2 | 2022 | 3571 | 0.410 |
Why?
|
Pharyngitis | 1 | 2014 | 215 | 0.410 |
Why?
|
Appointments and Schedules | 3 | 2021 | 414 | 0.410 |
Why?
|
Male | 49 | 2023 | 349538 | 0.410 |
Why?
|
Hospitals | 5 | 2019 | 3937 | 0.410 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1255 | 0.400 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1503 | 0.400 |
Why?
|
Drug Industry | 1 | 2017 | 744 | 0.400 |
Why?
|
Opiate Substitution Treatment | 5 | 2022 | 404 | 0.400 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2021 | 1457 | 0.390 |
Why?
|
Female | 49 | 2023 | 379592 | 0.390 |
Why?
|
Antiviral Agents | 1 | 2023 | 2978 | 0.380 |
Why?
|
Office Visits | 4 | 2022 | 598 | 0.380 |
Why?
|
Patient Readmission | 4 | 2019 | 3111 | 0.380 |
Why?
|
Health Care Surveys | 4 | 2020 | 2451 | 0.360 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3151 | 0.360 |
Why?
|
Dementia | 1 | 2023 | 2501 | 0.350 |
Why?
|
Health Policy | 2 | 2022 | 2657 | 0.350 |
Why?
|
Caregivers | 1 | 2021 | 2074 | 0.340 |
Why?
|
Inappropriate Prescribing | 4 | 2021 | 202 | 0.340 |
Why?
|
Health Status | 1 | 2022 | 4030 | 0.340 |
Why?
|
Motivation | 1 | 2019 | 1968 | 0.330 |
Why?
|
Veterans | 2 | 2019 | 2513 | 0.330 |
Why?
|
Emergency Service, Hospital | 6 | 2021 | 7645 | 0.320 |
Why?
|
Inpatients | 2 | 2017 | 2495 | 0.310 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1461 | 0.310 |
Why?
|
Middle Aged | 28 | 2023 | 213127 | 0.300 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3014 | 0.300 |
Why?
|
Emergency Medicine | 1 | 2017 | 1205 | 0.300 |
Why?
|
Rural Population | 4 | 2021 | 2207 | 0.290 |
Why?
|
Patients | 3 | 2023 | 892 | 0.290 |
Why?
|
Diagnosis-Related Groups | 2 | 2021 | 454 | 0.290 |
Why?
|
Hospitalization | 5 | 2023 | 10232 | 0.280 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2211 | 0.280 |
Why?
|
Length of Stay | 3 | 2023 | 6294 | 0.280 |
Why?
|
Adult | 25 | 2022 | 213712 | 0.280 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3391 | 0.270 |
Why?
|
Students, Medical | 1 | 2019 | 1858 | 0.270 |
Why?
|
Mortality | 1 | 2017 | 2857 | 0.260 |
Why?
|
Clinical Competence | 1 | 2021 | 4681 | 0.260 |
Why?
|
Mental Health | 1 | 2019 | 2997 | 0.260 |
Why?
|
Hospital Costs | 1 | 2012 | 980 | 0.260 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2749 | 0.260 |
Why?
|
Baclofen | 2 | 2022 | 128 | 0.240 |
Why?
|
Health Facilities | 2 | 2020 | 573 | 0.230 |
Why?
|
Vulnerable Populations | 2 | 2020 | 685 | 0.220 |
Why?
|
Aged, 80 and over | 13 | 2021 | 57683 | 0.220 |
Why?
|
Carisoprodol | 1 | 2022 | 5 | 0.220 |
Why?
|
Methocarbamol | 1 | 2022 | 7 | 0.220 |
Why?
|
Young Adult | 10 | 2020 | 56350 | 0.220 |
Why?
|
Cohort Studies | 9 | 2023 | 40450 | 0.210 |
Why?
|
Advanced Practice Nursing | 1 | 2022 | 18 | 0.210 |
Why?
|
Mental Disorders | 5 | 2023 | 6587 | 0.210 |
Why?
|
Databases, Factual | 4 | 2021 | 7716 | 0.210 |
Why?
|
Episode of Care | 2 | 2021 | 126 | 0.210 |
Why?
|
Specialty Boards | 1 | 2023 | 227 | 0.200 |
Why?
|
Physicians' Offices | 1 | 2021 | 58 | 0.200 |
Why?
|
New York City | 2 | 2020 | 706 | 0.200 |
Why?
|
Health Facilities, Proprietary | 1 | 2021 | 37 | 0.200 |
Why?
|
Naltrexone | 1 | 2023 | 307 | 0.190 |
Why?
|
Texas | 1 | 2022 | 392 | 0.190 |
Why?
|
Retrospective Studies | 9 | 2023 | 77098 | 0.190 |
Why?
|
Lorazepam | 1 | 2021 | 145 | 0.190 |
Why?
|
Naloxone | 1 | 2023 | 367 | 0.190 |
Why?
|
Neuromuscular Agents | 1 | 2022 | 134 | 0.190 |
Why?
|
Organizations, Nonprofit | 1 | 2021 | 104 | 0.180 |
Why?
|
Massachusetts | 5 | 2021 | 8662 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2276 | 0.180 |
Why?
|
Drug Resistance, Microbial | 2 | 2023 | 860 | 0.180 |
Why?
|
Ohio | 1 | 2020 | 337 | 0.180 |
Why?
|
Fees and Charges | 1 | 2021 | 195 | 0.180 |
Why?
|
Michigan | 1 | 2020 | 350 | 0.180 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2020 | 168 | 0.170 |
Why?
|
Students | 2 | 2019 | 1647 | 0.170 |
Why?
|
Electronic Mail | 1 | 2020 | 213 | 0.160 |
Why?
|
Homicide | 1 | 2021 | 287 | 0.160 |
Why?
|
Hospitals, Psychiatric | 1 | 2019 | 332 | 0.160 |
Why?
|
United States Department of Veterans Affairs | 2 | 2019 | 874 | 0.160 |
Why?
|
Cyclonic Storms | 1 | 2019 | 119 | 0.160 |
Why?
|
Medical Audit | 1 | 2019 | 467 | 0.150 |
Why?
|
Poverty | 2 | 2021 | 2646 | 0.150 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2017 | 93 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 365 | 0.150 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 312 | 0.150 |
Why?
|
Cost Control | 1 | 2019 | 624 | 0.140 |
Why?
|
Professional Practice | 1 | 2019 | 326 | 0.140 |
Why?
|
Los Angeles | 1 | 2017 | 238 | 0.140 |
Why?
|
Wounds and Injuries | 2 | 2021 | 2400 | 0.140 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 163 | 0.140 |
Why?
|
Logistic Models | 3 | 2017 | 13403 | 0.140 |
Why?
|
Frail Elderly | 1 | 2020 | 691 | 0.130 |
Why?
|
Accidents, Traffic | 1 | 2021 | 819 | 0.130 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 547 | 0.130 |
Why?
|
Adolescent | 7 | 2021 | 85649 | 0.130 |
Why?
|
Politics | 1 | 2022 | 790 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1679 | 0.130 |
Why?
|
Neoplasms | 1 | 2024 | 21596 | 0.130 |
Why?
|
Prescription Drugs | 1 | 2022 | 595 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 546 | 0.130 |
Why?
|
Behavior, Addictive | 1 | 2020 | 460 | 0.120 |
Why?
|
Risk Assessment | 4 | 2022 | 23320 | 0.120 |
Why?
|
Safety Management | 1 | 2020 | 782 | 0.120 |
Why?
|
Professional Role | 1 | 2017 | 306 | 0.120 |
Why?
|
California | 1 | 2018 | 1400 | 0.120 |
Why?
|
Documentation | 1 | 2020 | 865 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1146 | 0.120 |
Why?
|
Community Networks | 2 | 2013 | 203 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2020 | 854 | 0.120 |
Why?
|
Clostridium Infections | 2 | 2017 | 548 | 0.110 |
Why?
|
Social Stigma | 1 | 2019 | 698 | 0.110 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3649 | 0.110 |
Why?
|
Reimbursement, Incentive | 1 | 2018 | 540 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2414 | 0.110 |
Why?
|
Lower Extremity | 1 | 2020 | 1151 | 0.110 |
Why?
|
Medicare Part D | 1 | 2017 | 326 | 0.110 |
Why?
|
Social Class | 1 | 2021 | 1995 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1179 | 0.100 |
Why?
|
Health Facility Size | 1 | 2012 | 64 | 0.100 |
Why?
|
Contracts | 1 | 2012 | 60 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 521 | 0.100 |
Why?
|
Public Health | 2 | 2023 | 2594 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 758 | 0.100 |
Why?
|
Suicide | 1 | 2021 | 1475 | 0.090 |
Why?
|
Time Factors | 3 | 2023 | 40054 | 0.090 |
Why?
|
Bacterial Infections | 1 | 2018 | 1389 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1638 | 0.090 |
Why?
|
Child | 6 | 2023 | 77478 | 0.090 |
Why?
|
Age Factors | 2 | 2018 | 18355 | 0.090 |
Why?
|
Hospitals, Urban | 1 | 2012 | 499 | 0.090 |
Why?
|
Integrin beta3 | 1 | 2010 | 122 | 0.090 |
Why?
|
Vaccination | 1 | 2021 | 3256 | 0.090 |
Why?
|
Pain Measurement | 1 | 2019 | 3418 | 0.090 |
Why?
|
Ownership | 1 | 2012 | 331 | 0.090 |
Why?
|
Health Care Reform | 1 | 2018 | 1261 | 0.080 |
Why?
|
Family | 1 | 2020 | 3144 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6452 | 0.080 |
Why?
|
Disabled Persons | 1 | 2018 | 1209 | 0.080 |
Why?
|
Acute Disease | 2 | 2021 | 7141 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2640 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2589 | 0.080 |
Why?
|
Hospital Administration | 1 | 2012 | 353 | 0.080 |
Why?
|
Cross Infection | 1 | 2017 | 1413 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2022 | 4231 | 0.080 |
Why?
|
Mental Health Services | 1 | 2018 | 1643 | 0.070 |
Why?
|
Heart Arrest | 1 | 2017 | 1469 | 0.070 |
Why?
|
Fracture Healing | 1 | 2010 | 426 | 0.070 |
Why?
|
Tibial Fractures | 1 | 2010 | 269 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1653 | 0.070 |
Why?
|
Patient Care | 1 | 2012 | 639 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11001 | 0.070 |
Why?
|
Choice Behavior | 1 | 2011 | 802 | 0.070 |
Why?
|
Risk | 1 | 2017 | 9679 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3510 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9846 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3839 | 0.060 |
Why?
|
Pain | 1 | 2019 | 4961 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14720 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3203 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1436 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12958 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2021 | 21719 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2020 | 2536 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12242 | 0.060 |
Why?
|
ROC Curve | 1 | 2011 | 3528 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2017 | 5310 | 0.060 |
Why?
|
Orphenadrine | 1 | 2022 | 4 | 0.060 |
Why?
|
Chlorzoxazone | 1 | 2022 | 7 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5724 | 0.050 |
Why?
|
Hydrocodone | 1 | 2022 | 46 | 0.050 |
Why?
|
Patient Care Team | 1 | 2014 | 2527 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6754 | 0.050 |
Why?
|
Amitriptyline | 1 | 2022 | 110 | 0.050 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2021 | 35 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9144 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7770 | 0.050 |
Why?
|
Insurance Claim Review | 2 | 2018 | 720 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10392 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7276 | 0.050 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2021 | 57 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12730 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39004 | 0.050 |
Why?
|
Muscle Relaxants, Central | 1 | 2021 | 86 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 322 | 0.050 |
Why?
|
Risk Factors | 4 | 2021 | 72145 | 0.050 |
Why?
|
Hypertension | 1 | 2019 | 8455 | 0.040 |
Why?
|
Homes for the Aged | 1 | 2021 | 260 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2021 | 449 | 0.040 |
Why?
|
Rehabilitation | 1 | 2020 | 134 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9305 | 0.040 |
Why?
|
Financial Management, Hospital | 1 | 2018 | 74 | 0.040 |
Why?
|
Substance Abuse Detection | 1 | 2020 | 283 | 0.040 |
Why?
|
Clinical Coding | 1 | 2018 | 171 | 0.040 |
Why?
|
General Practitioners | 1 | 2018 | 103 | 0.040 |
Why?
|
Insurance | 1 | 2018 | 111 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 824 | 0.040 |
Why?
|
Drug Interactions | 1 | 2021 | 1458 | 0.040 |
Why?
|
Physicians, Family | 1 | 2018 | 345 | 0.040 |
Why?
|
Minority Groups | 1 | 2024 | 1215 | 0.030 |
Why?
|
Workplace | 1 | 2021 | 836 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20774 | 0.030 |
Why?
|
Perception | 1 | 2021 | 1188 | 0.030 |
Why?
|
Child, Preschool | 2 | 2018 | 40955 | 0.030 |
Why?
|
Peer Group | 1 | 2018 | 635 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1158 | 0.030 |
Why?
|
Income | 1 | 2021 | 1904 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2680 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2012 | 25575 | 0.030 |
Why?
|
Internal Medicine | 1 | 2018 | 1009 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 62966 | 0.020 |
Why?
|
Bony Callus | 1 | 2010 | 36 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6483 | 0.020 |
Why?
|
Infant | 1 | 2012 | 35070 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10372 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3070 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8297 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6534 | 0.020 |
Why?
|
Cartilage | 1 | 2010 | 818 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15194 | 0.020 |
Why?
|
Tibia | 1 | 2010 | 1075 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20928 | 0.010 |
Why?
|
Decision Making | 1 | 2012 | 3869 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14554 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13853 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18006 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81045 | 0.000 |
Why?
|
Animals | 1 | 2010 | 168561 | 0.000 |
Why?
|